Third Wave CEO Bought 5,000 Shares After Stock Fell | GenomeWeb

NEW YORK, March 17 (GenomeWeb News) - John Puisis, CEO of Third Wave Technologies, purchased 5,000 of his company's shares on March 15 at the low point of a stock-price slide precipitated by disappointing fourth quarter earnings, GenomeWeb News has learned.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.